US Broker Ratings

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 35.55% Potential Upside with a Strong Hold Consensus

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, has become a focal point for investors eyeing opportunities in the..

Twist Bioscience Corporation (TWST): Analyst Consensus and Growth Potential Highlight a Promising Investment Opportunity

Twist Bioscience Corporation (NASDAQ: TWST), a leader in the synthetic DNA industry, is garnering attention from investors thanks to its robust growth potential and strong analyst ratings. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Biotechnology Pioneer with 256.30% Potential Upside

In the dynamic world of biotechnology, Janux Therapeutics, Inc. (NASDAQ: JANX) stands out as a promising player with a focus on cutting-edge immunotherapies. This clinical-stage biopharmaceutical company is dedicated to..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Powerhouse with a 132.91% Potential Upside

Crinetics Pharmaceuticals, Inc. (CRNX), a San Diego-based biotechnology firm, is currently capturing the attention of investors with its promising pipeline and significant potential upside. The company boasts a market capitalization..

Celldex Therapeutics (CLDX) Stock Analysis: Exploring a Potential 187.80% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing opportunity for investors in the biotechnology sector, primarily due to its promising pipeline in therapeutic antibodies and an analyst consensus pointing towards..

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 35.82% Upside Potential in the Medical Devices Market

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices sector, has positioned itself as an intriguing prospect for investors looking to capitalize on the healthcare industry’s growth potential...

Viking Therapeutics, Inc. (VKTX): Analyst Ratings Highlight a Potential 234% Upside for Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing investor attention with its strong potential for substantial gains. Known for its innovative approach in the biotechnology sector, Viking Therapeutics is carving its..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 108% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector should take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). This San Diego-based biopharmaceutical company is making waves with its innovative..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 120% Upside in the Biotech Arena

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company based in South San Francisco, California, stands as a significant player in the biotechnology sector. With a market capitalization of $2.12 billion,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 37% Potential Upside and Strong Buy Ratings

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specializes in operating outpatient physical therapy clinics across the United States. Founded in 1990 and headquartered in..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Assessing the 133% Upside Potential

Travere Therapeutics, Inc. (NASDAQ: TVTX) presents a compelling opportunity for investors with its focus on rare kidney and metabolic diseases, evidenced by a notable potential upside of 133.42% according to..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Virtual Healthcare Landscape with a 27.83% Upside Potential

Teladoc Health, Inc. (TDOC) stands as a pivotal player in the healthcare sector, specifically within the burgeoning field of health information services. As a pioneer in virtual healthcare, Teladoc Health..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating Rapid Growth Amidst Uncertain Valuation

Ascentage Pharma Group International (AAPG), a prominent player in the healthcare sector, has piqued investor interest with its impressive revenue growth. Despite this promising figure, the clinical-stage biotechnology company faces..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 24.64% Potential Upside in the Fertility Benefits Market

Progyny, Inc. (NASDAQ: PGNY), a leader in fertility and family-building healthcare solutions, presents an intriguing opportunity for investors in the healthcare sector. With a market capitalization of $1.81 billion, Progyny..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 92% Potential Upside for Investors

Astrana Health Inc. (NASDAQ: ASTH), a key player in the healthcare management sector, is capturing investor attention with a compelling potential upside of 92.02%. Known for its comprehensive medical care..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 14% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in operating senior living communities across the United States. The company, headquartered in Brentwood, Tennessee, is..

Structure Therapeutics Inc. (GPCR): Investor Outlook on a Potential 271% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its remarkable potential upside of 271.03%, positioning itself as a noteworthy player in the biotechnology sector. The company,..

ICU Medical, Inc. (ICUI) Stock Analysis: A 39.75% Potential Upside Awaits Investors

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors seeking exposure to the medical devices..

PACS Group, Inc. (PACS) Stock Analysis: A Robust 250% Potential Upside Ignites Investor Interest

Investors looking for opportunities in the healthcare sector may find PACS Group, Inc. (PACS) intriguing, with its promising potential upside of 250.10%. Headquartered in Farmington, Utah, PACS Group operates skilled..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A 24% Upside Potential Amidst a Challenging Revenue Landscape

Pediatrix Medical Group, Inc. (NASDAQ: MD) stands as a notable player in the healthcare sector, specializing in providing newborn, maternal-fetal, and pediatric subspecialty care services across the United States. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds